Wegovy Wegovy, another GLP-1 receptor agonist, is specifically approved for weight loss in addition to its use as a diabetes medication
Limit empty calories like sugary drinks or junk food with a smaller appetite, every bite counts
Clinical studies have found that this is an effective weight loss solution for overweight and obese patients
Regulation of lipolysis in adipocytes
1 Side effects and contraindications Currently, patients with a history of pancreatitis, kidney disease, active gall bladder disease, medullary thyroid cancer, multiple endocrine neoplasia, and any allergy to this medicine are advised against taking these medications
Users should verify the cost with their healthcare provider and insurance plan for the most accurate information